✦ LIBER ✦

Safety, tolerability and pharmacokinetics of SUVN-502 - A 5-HT6 receptor antagonist, first in human phase-1 Single Ascending Dose (SAD) study

✍ Scribed by Ramakrishna Nirogi; Vishwottam Kandikere; Koteshwara Mudigonda; Gopinadh Bhyrapuneni; Venkat Jasti

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human phase-1 Multiple Ascending Dose (M

✍ Ramakrishna Nirogi; Vishwottam Kandikere; Koteshwara Mudigonda; Gopinadh Bhyrapu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB

SUVN-502: A safe, potent, selective, bra

✍ Ramakrishna Nirogi; Ramasastri Kambhampati; Anil Shinde; Vishwottam Kandikere; K 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

P.11.14 Phase 1b single and multiple asc

✍ Escolar, D.M.; Davis-Golden, J.; Loewy, J.; Bush, E.; Dykstra, K.; Blaustein, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Single- and multiple-dose safety, tolera

✍ Bell, Joanne; Baird-Bellaire, Susan; Leil, Tarek; Comery, Thomas; Plotka, Anna; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Safety, Tolerability, Pharmacokinetics a

✍ Okusaka, T.; Ikeda, M.; Fukutomi, A.; Kobayashi, Y.; Shibayama, K.; Takubo, T.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 157 KB